Seagen
SGEN
#546
Rank
C$59.61 B
Marketcap
C$316.00
Share price
-0.07%
Change (1 day)
66.44%
Change (1 year)

Revenue for Seagen (SGEN)

Revenue in 2023 (TTM): C$3.10 Billion

According to Seagen 's latest financial reports the company's current revenue (TTM ) is C$3.17 Billion. In 2022 the company made a revenue of C$2.66 Billion an increase over the revenue in the year 2021 that were of C$2.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seagen from 2001 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) C$3.10 B16.43%
2022 C$2.66 B32.72%
2021 C$2.00 B-27.67%
2020 C$2.77 B131.69%
2019 C$1.19 B34.25%
2018 C$0.89 B47.09%
2017 C$0.60 B7.9%
2016 C$0.56 B20.27%
2015 C$0.46 B40.4%
2014 C$0.33 B16.1%
2013 C$0.28 B36.73%
2012 C$0.20 B117.44%
2011 C$96.4 M-10.26%
2010 C$0.10 B96.47%
2009 C$54.67 M27.62%
2008 C$42.84 M91.55%
2007 C$22.36 M92%
2006 C$11.64 M2.55%
2005 C$11.35 M41.14%
2004 C$8.04 M22.37%
2003 C$6.57 M147.34%
2002 C$2.65 M508.88%
2001 C$0.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ImmunoGen
IMGN
C$0.39 B-87.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.90 B 337.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$3.59 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$35.54 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 2,629.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$58.51 B 1,741.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
C$82.39 B 2,492.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$66.35 B 1,988.12%๐Ÿ‡บ๐Ÿ‡ธ USA